Citation: Rs. Weiner et al., A SENSITIVE ENZYME-IMMUNOASSAY FOR THE QUANTITATION OF HUMAN CTLA4IG FUSION PROTEIN IN MOUSE SERUM - PHARMACOKINETIC APPLICATION TO OPTIMIZING CELL-LINE SELECTION, Journal of pharmaceutical and biomedical analysis, 15(5), 1997, pp. 571-579
Authors:
SRINIVAS NR
SHYU WC
WEINER RS
WARNER G
COMERESKI C
TAY LK
GREENE DS
BARBHAIYA RH
Citation: Nr. Srinivas et al., ASSESSMENT OF DOSE PROPORTIONALITY, ABSOLUTE BIOAVAILABILITY, AND IMMUNOGENICITY RESPONSE OF CTLA4IG (BMS-188667), A NOVEL IMMUNOSUPPRESSIVE AGENT, FOLLOWING SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION TO RATS, Pharmaceutical research, 14(7), 1997, pp. 911-916
Citation: Rs. Weiner, COPYRIGHT IN A DIGITAL AGE - PRACTICAL GUIDANCE FOR INFORMATION PROFESSIONALS IN THE MIDST OF LEGAL UNCERTAINTY, Online, 21(3), 1997, pp. 97-102
Authors:
SONNICHSEN DS
SUMMERILL RS
RAYMOND RH
WEINER RS
ABRAMS JR
BIRKHOFER MJ
Citation: Ds. Sonnichsen et al., PHARMACOKINETIC (PK) MODELING OF BMS-188667 (CTLA4IG), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 104-104
Citation: Rs. Weiner, THE EFFECT OF POSTCURE HEAT-TREATMENT SYSTEMS ON COMPOSITE RESIN RESTORATIONS, The Journal of the American Dental Association, 128(1), 1997, pp. 88-88
Authors:
GALE RP
BUCHNER T
ZHANG MJ
HEINECKE A
CHAMPLIN RE
DICKE KA
GLUCKMAN E
GOOD RA
GRATWOHL A
HERZIG RH
KEATING A
KLEIN JP
MARMONT AM
PRENTICE HG
ROWLINGS PA
SOBOCINSKI KA
SPECK B
WEINER RS
HOROWITZ MM
Citation: Rp. Gale et al., HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS VS CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN FIRST REMISSION, Leukemia, 10(11), 1996, pp. 1687-1691
Authors:
SRINIVAS NR
WEINER RS
SHYU WC
CALORE JD
TRITSCHLER D
TAY LK
LEE JS
GREENE DS
BARBHAIYA RH
Citation: Nr. Srinivas et al., A PHARMACOKINETIC STUDY OF INTRAVENOUS CTLA4IG, A NOVEL IMMUNOSUPPRESSIVE AGENT, IN MICE, Journal of pharmaceutical sciences, 85(3), 1996, pp. 296-298
Authors:
SRINIVAS NR
WEINER RS
WARNER G
SHYU WC
DAVIDSON T
FADROWSKI CG
TAY LK
LEE JS
GREENE DS
BARBHAIYA RH
Citation: Nr. Srinivas et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CTLA4IG (BMS-188667), A NOVEL IMMUNOSUPPRESSIVE AGENT, IN MONKEYS FOLLOWING MULTIPLE DOSES, Journal of pharmaceutical sciences, 85(1), 1996, pp. 1-4
Citation: Rs. Weiner et al., TEACHING THE USE OF BASES AND LINERS - A SURVEY OF NORTH-AMERICAN DENTAL SCHOOLS, The Journal of the American Dental Association, 127(11), 1996, pp. 1640-1645
Authors:
VOGLER WR
WEINER RS
MOORE JO
OMURA GA
BARTOLUCCI AA
STAGG M
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED POSTINDUCTION THERAPY TRIAL IN ACUTE MYELOGENOUS LEUKEMIA - (A SOUTHEASTERN CANCER STUDY-GROUP TRIAL), Leukemia, 9(9), 1995, pp. 1456-1460
Authors:
GALE RP
HOROWITZ MM
WEINER RS
ASH RC
ATKINSON K
BABU R
DICKE KA
KLEIN JP
LOWENBERG B
REIFFERS J
RIMM AA
ROWLINGS PA
SANDBERG AA
SOBOCINSKI KA
VEUMSTONE J
BORTIN MM
Citation: Rp. Gale et al., IMPACT OF CYTOGENETIC ABNORMALITIES ON OUTCOME OF BONE-MARROW TRANSPLANTS IN ACUTE MYELOGENOUS LEUKEMIA IN FIRST REMISSION, Bone marrow transplantation, 16(2), 1995, pp. 203-208
Authors:
CIESLA J
WEINER KXB
WEINER RS
RESTON JT
MALEY GF
MALEY F
Citation: J. Ciesla et al., ISOLATION AND EXPRESSION OF RAT THYMIDYLATE SYNTHASE CDNA - PHYLOGENETIC COMPARISON WITH HUMAN AND MOUSE THYMIDYLATE SYNTHASES, Biochimica et biophysica acta, N. Gene structure and expression, 1261(2), 1995, pp. 233-242
Citation: Nr. Srinivas et al., PHARMACOKINETICS OF CTLA4IG (BMS-188667), A NOVEL IMMUNOSUPPRESSIVE AGENT, FOLLOWING INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION TO MICE, Journal of pharmaceutical sciences, 84(12), 1995, pp. 1488-1489
Authors:
MILLER AM
CONLEY NS
ALLEN B
HOOVER DL
WEINER RS
Citation: Am. Miller et al., BLEOMYCIN-INDUCED DIFFERENTIATION OF A HUMAN MONOBLAST CELL-LINE U937, Cancer research, therapy & control, 4(2), 1994, pp. 149-153
Citation: Jw. Lynch et al., PURE RED-CELL APLASIA ASSOCIATED WITH ANGIOIMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINEMIA, American journal of hematology, 46(2), 1994, pp. 72-78
Authors:
LAZARUS HM
GRAY R
CIOBANU N
WINTER J
WEINER RS
Citation: Hm. Lazarus et al., PHASE-I TRIAL OF HIGH-DOSE MELPHALAN, HIGH-DOSE ETOPOSIDE AND AUTOLOGOUS BONE-MARROW RE-INFUSION IN SOLID TUMORS - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) STUDY, Bone marrow transplantation, 14(3), 1994, pp. 443-448
Authors:
ROWE JM
CIOBANU N
ASCENSAO J
STADTMAUER EA
WEINER RS
SCHENKEIN DP
MCGLAVE P
LAZARUS HM
Citation: Jm. Rowe et al., RECOMMENDED GUIDELINES FOR THE MANAGEMENT OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG), Annals of internal medicine, 120(2), 1994, pp. 143-158
Citation: Kxb. Weiner et al., PRIMARY STRUCTURE OF HUMAN DEOXYCYTIDYLATE DEAMINASE AND OVEREXPRESSION OF ITS FUNCTIONAL PROTEIN IN ESCHERICHIA-COLI, The Journal of biological chemistry, 268(17), 1993, pp. 2983-2989
Authors:
MILLER AM
DEMPSEY H
WEINER RS
GROSS S
GRAHAMPOLE J
OBLON DJ
GREENE V
MYERS L
GROSS MA
HUTCHESON C
Citation: Am. Miller et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) DOES NOT PROMOTE STEM-CELL STEAL FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANT, Blood, 82(10), 1993, pp. 10000638-10000638